(Q45985045)

18 December 2017

title

Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population. (English)

1 reference

18 December 2017

1 reference

cardiovascular disease

1 reference

1 reference

1

1 reference

18 December 2017

John Beilby

object named as

John Beilby

5

0 references

Matthew Knuiman

object named as

Matthew W Knuiman

2

0 references

author name string

Mark L Divitini

3

1 reference

18 December 2017

Timothy M E Davis

4

1 reference

18 December 2017

Joseph Hung

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

2 June 2009

1 reference

18 December 2017

The American Journal of Gastroenterology

published in

1 reference

18 December 2017

volume

104

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

1715-1722

1 reference

18 December 2017

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Nonalcoholic fatty liver disease as a component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Effects of HFE gene mutations and alcohol on iron status, liver biochemistry and morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Population-based linkage of health records in Western Australia: development of a health services research linked database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

A population-based study of the clinical expression of the hemochromatosis gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.229

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.229

1 reference

18 December 2017

1 reference

18 December 2017